Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
Jas Bindra,1 Ishveen Chopra,2 John Niewoehner,3 Mary Panaccio,3 George J Wan3 1Falcon Research Group, North Potomac, MD, USA; 2Manticore Consultancy, Bethesda, MD, USA; 3Mallinckrodt Pharmaceuticals, Hampton, NJ, USACorrespondence: George J WanMallinckrodt Pharmaceuticals, 53 Frontage Road, Hampton,...
Saved in:
Main Authors: | Bindra J (Author), Chopra I (Author), Niewoehner J (Author), Panaccio M (Author), Wan GJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis
by: Hunter SF, et al.
Published: (2021) -
Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
by: Howard Busch, et al.
Published: (2022) -
Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2020) -
Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
by: George J Wan, et al.
Published: (2021) -
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis
by: Bindra J, et al.
Published: (2023)